However, in patients with non-small cell lung cancer (NSCLC) [11, 12], urothelial carcinoma (UC) [14] or glioma [13], the increased TUG1 expression is correlated with favorable survival. This evidence concerns the gene TUG1 and urothelial carcinoma.